DK2012816T3 - Anvendelse af Thymosin 1, alene eller i kombination med PTX3 eller Ganciclovir, til behandling af Cytomegalovirus infektion. - Google Patents
Anvendelse af Thymosin 1, alene eller i kombination med PTX3 eller Ganciclovir, til behandling af Cytomegalovirus infektion.Info
- Publication number
- DK2012816T3 DK2012816T3 DK07728041.0T DK07728041T DK2012816T3 DK 2012816 T3 DK2012816 T3 DK 2012816T3 DK 07728041 T DK07728041 T DK 07728041T DK 2012816 T3 DK2012816 T3 DK 2012816T3
- Authority
- DK
- Denmark
- Prior art keywords
- ptx3
- thymosin
- ganciclovir
- alone
- treatment
- Prior art date
Links
- 206010011831 Cytomegalovirus infection Diseases 0.000 title 1
- 101001082142 Homo sapiens Pentraxin-related protein PTX3 Proteins 0.000 title 1
- BFHAYPLBUQVNNJ-UHFFFAOYSA-N Pectenotoxin 3 Natural products OC1C(C)CCOC1(O)C1OC2C=CC(C)=CC(C)CC(C)(O3)CCC3C(O3)(O4)CCC3(C=O)CC4C(O3)C(=O)CC3(C)C(O)C(O3)CCC3(O3)CCCC3C(C)C(=O)OC2C1 BFHAYPLBUQVNNJ-UHFFFAOYSA-N 0.000 title 1
- 102100027351 Pentraxin-related protein PTX3 Human genes 0.000 title 1
- 102000007501 Thymosin Human genes 0.000 title 1
- 108010046075 Thymosin Proteins 0.000 title 1
- IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 title 1
- 229960002963 ganciclovir Drugs 0.000 title 1
- LCJVIYPJPCBWKS-NXPQJCNCSA-N thymosin Chemical compound SC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(O)=O)C(O)=O LCJVIYPJPCBWKS-NXPQJCNCSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Marine Sciences & Fisheries (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06113401 | 2006-05-02 | ||
| PCT/EP2007/053574 WO2007128647A1 (en) | 2006-05-02 | 2007-04-12 | USE OF THYMOSIN α1, ALONE OR IN COMBINATION WITH PTX3 OR GANCICLOVIR, FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2012816T3 true DK2012816T3 (da) | 2012-09-03 |
Family
ID=36658736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07728041.0T DK2012816T3 (da) | 2006-05-02 | 2007-04-12 | Anvendelse af Thymosin 1, alene eller i kombination med PTX3 eller Ganciclovir, til behandling af Cytomegalovirus infektion. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8337828B2 (https=) |
| EP (1) | EP2012816B1 (https=) |
| JP (1) | JP5441685B2 (https=) |
| KR (1) | KR101380360B1 (https=) |
| CN (1) | CN101437535B (https=) |
| AU (1) | AU2007247292B2 (https=) |
| BR (1) | BRPI0711136A2 (https=) |
| CA (1) | CA2649063C (https=) |
| CY (1) | CY1113277T1 (https=) |
| DK (1) | DK2012816T3 (https=) |
| ES (1) | ES2389452T3 (https=) |
| HR (1) | HRP20120676T1 (https=) |
| MX (1) | MX2008013872A (https=) |
| PL (1) | PL2012816T3 (https=) |
| PT (1) | PT2012816E (https=) |
| RS (1) | RS52377B (https=) |
| SI (1) | SI2012816T1 (https=) |
| WO (1) | WO2007128647A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1298487B1 (it) * | 1997-12-19 | 2000-01-10 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale, |
| ITRM20040223A1 (it) * | 2004-05-07 | 2004-08-07 | Sigma Tau Ind Farmaceuti | Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi. |
| EP1832295A1 (en) * | 2006-03-10 | 2007-09-12 | Tecnogen S.P.A. | Use of PTX3 for the treatment of viral diseases |
| US8829173B2 (en) * | 2008-09-26 | 2014-09-09 | Tocagen Inc. | Recombinant vectors |
| WO2010129947A2 (en) * | 2009-05-08 | 2010-11-11 | Sciclone Pharmaceuticals, Inc. | Alpha thymosin peptides as vaccine enhancers |
| US20140213506A1 (en) * | 2011-02-09 | 2014-07-31 | Cynthia W. TUTHILL | Thymosin alpha peptide for preventing, reducing the severity of, and treating infection |
| ES2786051T3 (es) | 2012-10-25 | 2020-10-08 | Tocagen Inc | Vector retroviral con casete de mini-promotor |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6106868A (en) * | 1990-08-24 | 2000-08-22 | The Board Of Governors Of Wayne State University | Method for the treatment of hepatitis |
| TW224053B (https=) * | 1991-09-13 | 1994-05-21 | Paul B Chretien | |
| CN1072961C (zh) * | 1993-03-05 | 2001-10-17 | 施塞克龙药品公司 | 治疗对干扰素治疗无反应者的丙型肝炎的方法 |
| US6200952B1 (en) * | 1993-06-02 | 2001-03-13 | Sciclone Pharmaceuticals, Inc. | Combination therapy method for treating chronic hepatitis B |
| US5632983A (en) * | 1994-11-17 | 1997-05-27 | University Of South Florida | Method for treating secondary immunodeficiency |
| WO1998018491A1 (en) * | 1996-10-28 | 1998-05-07 | BURGSTINER, Jacqueline, Cook | Methods and compositions for dietary supplementation |
| US5939423A (en) * | 1997-04-16 | 1999-08-17 | Sciclone Pharmaceuticals, Inc. | Treatment of hepatitis B infection with thymosin alpha 1 and famciclovir |
| IT1298487B1 (it) * | 1997-12-19 | 2000-01-10 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale, |
| US6288033B1 (en) * | 1998-09-25 | 2001-09-11 | Sciclone Pharmaceuticals, Inc. | Treatment of hepatitis B infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir |
| IT1317927B1 (it) | 2000-11-03 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie autoimmuni. |
| IT1317930B1 (it) | 2000-11-08 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patalogie associate ad una alterata attivazione |
| US20040198655A1 (en) | 2001-08-03 | 2004-10-07 | Alberto Mantovani | Use of long pentraxin ptx3 for treating female infertility |
| WO2003035111A1 (en) * | 2001-10-24 | 2003-05-01 | Sciclone Pharmaceuticals, Inc. | Antiretroviral compositions comprising thymosin alpha peptides and protease inhibitors |
| JP2006524704A (ja) * | 2003-04-23 | 2006-11-02 | サイクローン・ファーマシューティカルズ・インコーポレイテッド | アルファチモシンペプチドによる呼吸器ウイルス感染の治療または予防 |
| ITRM20030596A1 (it) | 2003-12-23 | 2005-06-24 | Sigma Tau Ind Farmaceuti | Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3. |
| EP1832295A1 (en) * | 2006-03-10 | 2007-09-12 | Tecnogen S.P.A. | Use of PTX3 for the treatment of viral diseases |
-
2007
- 2007-04-12 RS RS20120363A patent/RS52377B/sr unknown
- 2007-04-12 EP EP07728041A patent/EP2012816B1/en active Active
- 2007-04-12 KR KR1020087029405A patent/KR101380360B1/ko not_active Expired - Fee Related
- 2007-04-12 DK DK07728041.0T patent/DK2012816T3/da active
- 2007-04-12 PT PT07728041T patent/PT2012816E/pt unknown
- 2007-04-12 WO PCT/EP2007/053574 patent/WO2007128647A1/en not_active Ceased
- 2007-04-12 HR HRP20120676TT patent/HRP20120676T1/hr unknown
- 2007-04-12 SI SI200730976T patent/SI2012816T1/sl unknown
- 2007-04-12 ES ES07728041T patent/ES2389452T3/es active Active
- 2007-04-12 CA CA2649063A patent/CA2649063C/en not_active Expired - Fee Related
- 2007-04-12 BR BRPI0711136-3A patent/BRPI0711136A2/pt not_active IP Right Cessation
- 2007-04-12 US US12/298,643 patent/US8337828B2/en not_active Expired - Fee Related
- 2007-04-12 AU AU2007247292A patent/AU2007247292B2/en not_active Ceased
- 2007-04-12 JP JP2009508294A patent/JP5441685B2/ja not_active Expired - Fee Related
- 2007-04-12 MX MX2008013872A patent/MX2008013872A/es active IP Right Grant
- 2007-04-12 PL PL07728041T patent/PL2012816T3/pl unknown
- 2007-04-12 CN CN2007800159035A patent/CN101437535B/zh not_active Expired - Fee Related
-
2012
- 2012-08-23 CY CY20121100756T patent/CY1113277T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101437535A (zh) | 2009-05-20 |
| KR20090007621A (ko) | 2009-01-19 |
| BRPI0711136A2 (pt) | 2011-08-30 |
| PT2012816E (pt) | 2012-08-17 |
| CA2649063C (en) | 2014-11-25 |
| CN101437535B (zh) | 2013-01-30 |
| RS52377B (sr) | 2012-12-31 |
| JP2009535373A (ja) | 2009-10-01 |
| AU2007247292B2 (en) | 2012-04-05 |
| ES2389452T3 (es) | 2012-10-26 |
| JP5441685B2 (ja) | 2014-03-12 |
| US8337828B2 (en) | 2012-12-25 |
| CA2649063A1 (en) | 2007-11-15 |
| SI2012816T1 (sl) | 2012-09-28 |
| CY1113277T1 (el) | 2016-04-13 |
| AU2007247292A1 (en) | 2007-11-15 |
| MX2008013872A (es) | 2008-11-14 |
| WO2007128647A1 (en) | 2007-11-15 |
| HK1128622A1 (en) | 2009-11-06 |
| PL2012816T3 (pl) | 2012-11-30 |
| HRP20120676T1 (hr) | 2012-09-30 |
| KR101380360B1 (ko) | 2014-04-09 |
| US20090275508A1 (en) | 2009-11-05 |
| EP2012816B1 (en) | 2012-06-27 |
| EP2012816A1 (en) | 2009-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR17C1020I2 (fr) | Fsh recombinante comprenant la sialylation alpha 2,3 et alpha 2,6 | |
| PL1858917T3 (pl) | Szczepionka przeciw wirusowi ospy wietrznej i półpaśca | |
| DK2012816T3 (da) | Anvendelse af Thymosin 1, alene eller i kombination med PTX3 eller Ganciclovir, til behandling af Cytomegalovirus infektion. | |
| DK2375907T3 (da) | Behandling af sygdomme, lidelser eller tilstande i lungerne under anvendelse af placentaceller | |
| DK2120999T3 (da) | Farmaceutiske sammensætninger omfattende Activin-ActRIIA antagonister samt anvendelse deraf ved forebyggelse eller behandling af multipelt myelom | |
| NO20054705D0 (no) | Forbedringer ved eller i forbindelse med sentrifuger | |
| EP2288324A4 (en) | ABSORBENT HYGIENE WITH DISPENSER | |
| BRPI0719345A2 (pt) | Di-hidroimidazóis substituídos e seu uso no tratamento de tumores. | |
| EP2185202A4 (en) | USE OF INTERLEUKIN-22 FOR THE TREATMENT OF FATTLEBER | |
| BRPI0721783A2 (pt) | "meio multicamada carregado e respirador" | |
| CL2008002353A1 (es) | Compuestos derivados de 7h-indolo[2,1-a][2]benzazepina; composicion farmaceutica; y uso en el tratamiento de la hepatitis c. | |
| BRPI0812766A2 (pt) | 4-cloro-4-alcóxi-1,1,1-triflúor-2-butanonas, preparação das mesmas e uso das mesmas no preparo de 4-alcóxi-1,1,1-triflúor-3-buten-2-onas | |
| BRPI0813602A2 (pt) | "dispositivo de travamento, nacela de turbojato e aeronave" | |
| EP1877344A4 (en) | BIOFILTER UNITS AND WATER TREATMENT PLANTS THEREWITH | |
| DK3156057T3 (da) | Delmopinol-belagt dyretyggeartikel til anvendelse til forebyggelsen eller behandlingen af halitosis | |
| NO20053140D0 (no) | Ror med kanal i rorveggen. | |
| DK1993585T3 (da) | Anvendelse af den lange pentraxin PTX3 til forebyggelse eller behandling af virussygdomme | |
| FI20060989L (fi) | Järjestely hissin nopeudenrajoittimessa | |
| DK2193789T3 (da) | Anvendelse af 3,5-dihydroxytoluen eller derivater deraf i fremstillingen af medicin og funktionelle fødevarer til behandling eller forebyggelse af depression | |
| CL2007001003A1 (es) | Compuestos derivados de amidas; y uso en el tratamiento de un trastorno asociado con el virus de hepatitis c. | |
| FI20060864A0 (fi) | Integroitu systeemi, laite ja niiden käyttö | |
| BRPI0818807A2 (pt) | Método para inibir lesão de reperfusão e/ou enfarte em um paciente em necessidade do mesmo, e, uso de um inibidor de glicoproteína vi de plaqueta | |
| ITRM20040489A1 (it) | Pentraxina lunga ptx3 deglicosilata o desialidata. | |
| 張全真 et al. | The Person Pronoun System of Liwen | |
| JI | The biological characteristics of clam Moerella iridescens inshore in Zhejiang Province |